Lista de obras -

A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease

artículo científico publicado en 2016

A systematic review of infliximab in the treatment of early rheumatoid arthritis

artículo científico publicado en 2007

Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions

artículo científico publicado en 2011

Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory

scientific journal article

Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee

artículo científico publicado en 2014

Adverse events of biologic therapies

artículo científico publicado en 2017

Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure

artículo científico publicado en 2009

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis

scholarly article by Nicolas Vuilleumier et al published 6 May 2010 in Arthritis and Rheumatism

Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.

artículo científico publicado en 2004

Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice ⬇️

artículo científico publicado el 9 de noviembre de 2011

Assessment of the efficacy of different statins in murine collagen-induced arthritis

artículo científico publicado en 2004

At the horizon of innovative therapy in rheumatology: new biologic agents

artículo científico publicado en 2008

Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling

artículo científico publicado en 2015

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

artículo científico publicado en 2013

CD14 is an acute-phase protein

artículo científico publicado en 2004

Cardiovascular risk in patients with rheumatoid arthritis

artículo científico publicado en 2017

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies

artículo científico publicado en 2009

Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome ⬇️

artículo científico publicado el 2 de junio de 2013

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod

scholarly article by Kim Lauper et al published 5 May 2018 in Annals of the Rheumatic Diseases

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance

artículo científico publicado en 2018

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

artículo científico publicado en 2009

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

artículo científico publicado en 2015

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

artículo científico publicado en 2012

Cytokine inhibitors in the treatment of rheumatoid arthritis

artículo científico publicado en 2002

Cytokines in the rheumatic diseases

artículo científico publicado en 2004

Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice

artículo científico publicado en 2004

Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients

artículo científico publicado en 2010

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency ⬇️

artículo científico publicado el 16 de enero de 2013

Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice

artículo científico publicado en 2010

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

artículo científico publicado en 2012

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

artículo científico publicado en 2010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

artículo científico publicado en 2017

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

artículo científico publicado en 2015

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

artículo científico publicado en 2011

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

artículo científico publicado en 2015

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

artículo científico publicado en 2016

Elevated serum levels of free interleukin-18 in adult-onset Still's disease

artículo científico publicado en 2016

Endogenous IL-1α is a chromatin-associated protein in mouse macrophages ⬇️

artículo científico publicado el 14 de mayo de 2013

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

artículo científico publicado en 2016

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

artículo científico publicado en 2012

Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis

artículo científico publicado en 2007

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

artículo científico publicado en 2012

Expression and function of junctional adhesion molecule-C in human and experimental arthritis

artículo científico publicado en 2007

Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis

artículo científico publicado en 2017

Hand osteoarthritis: new insights

artículo científico

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

artículo científico publicado en 2011

IL-1 pathways in inflammation and human diseases

artículo científico publicado en 2010

IL-1 trap. Regeneron/Novartis.

artículo científico publicado en 2003

IL-1, IL-18, and IL-33 families of cytokines

artículo científico publicado en 2008

IL-1R1-MyD88 axis elicits papain-induced lung inflammation.

artículo científico publicado en 2016

IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells

scientific journal article

IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro

artículo científico publicado en 2017

Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study

artículo científico publicado en 2018

Immune-mediated experimental arthritis in IL-33 deficient mice

artículo científico publicado en 2014

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

artículo científico publicado en 2011

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

artículo científico publicado en 2017

In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians

artículo científico publicado en 2014

Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice

artículo científico

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study

artículo científico publicado en 2015

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

artículo científico publicado en 2007

Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis.

artículo científico publicado en 1999

Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice

artículo científico publicado en 2005

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

artículo científico publicado en 2018

Interleukin-33 biology with potential insights into human diseases ⬇️

artículo científico publicado el 26 de abril de 2011

Interleukin-33 is biologically active independently of caspase-1 cleavage

artículo científico publicado en 2009

Interleukin-6 and chronic inflammation

artículo científico publicado en 2006

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus

artículo científico publicado en 2017

Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system

artículo científico publicado en 2015

Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility

artículo científico publicado en 2005

Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease

artículo científico publicado en 2012

Is IL-1 a good therapeutic target in the treatment of arthritis?

artículo científico publicado en 2006

Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?

artículo científico publicado en 2014

Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis ⬇️

artículo científico publicado el 15 de enero de 2002

Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa B/PU.1 binding site

artículo científico publicado en 2003

Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition

artículo científico publicado en 2016

Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection

artículo científico publicado en 2015

Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice

scientific article published on 19 May 2009

Mice deficient in hepatocyte‐specific IL‐1Ra show delayed resolution of concanavalin A‐induced hepatitis ⬇️

artículo científico publicado el 1 de mayo de 2012

Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein

artículo científico publicado en 2007

Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions

artículo científico publicado en 2013

Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout

artículo científico publicado en 2014

Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment

artículo científico publicado en 2018

Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé-Cameroon

artículo científico publicado en 2009

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

artículo científico publicado en 2018

Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study

artículo científico publicado en 2015

Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).

artículo científico publicado en 2005

Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype

artículo científico publicado en 2017

Prevotella copri in individuals at risk for rheumatoid arthritis.

artículo científico publicado en 2019

Primary human articular chondrocytes, dedifferentiated chondrocytes, and synoviocytes exhibit differential responsiveness to interleukin-4: correlation with the expression pattern of the common receptor gamma chain

artículo científico publicado en 2002

Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo

scientific article published on 01 February 2001

Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts

artículo científico publicado en 2004

Prolonged treatment with Tadekinig alfa in adult-onset Still's disease

article

Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience

artículo científico

Regulation and function of interleukin-36 cytokines

artículo científico publicado en 2018

Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions

artículo científico publicado en 2015

Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis".

artículo científico publicado en 2012

Rheumatoid arthritis: from basic findings and clinical manifestations to future therapies

artículo científico publicado en 2017

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

artículo científico publicado en 2017

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

artículo científico publicado en 2015

SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype

artículo científico publicado en 2015

Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis

artículo científico publicado en 2017

Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins ⬇️

artículo científico publicado el 16 de septiembre de 2010

Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion

artículo científico publicado en 2002

Spondylarthropathies in 2015

artículo científico publicado en 2016

Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection

artículo científico publicado en 2010

Synovial tissues concentrate secreted APRIL.

artículo científico publicado en 2009

Systemic rheumatoid vasculitis: a review

artículo científico publicado en 2006

The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans

artículo científico publicado en 2013

The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis

artículo científico publicado en 2016

The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

artículo científico publicado en 2008

The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes

artículo científico publicado en 2004

The advent of biosimilars: challenges and risks

artículo científico publicado en 2014

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases

artículo científico publicado en 2009

The mouseinterleukin (Il)33gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters ⬇️

artículo científico publicado el 19 de octubre de 2011

The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

artículo científico publicado en 2017

The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14.

artículo científico publicado en 2008

The role of female hormonal factors in the development of rheumatoid arthritis

artículo científico publicado en 2016

The role of leptin in innate and adaptive immune responses

artículo científico publicado en 2006

The severity of experimental arthritis is independent of IL-36 receptor signaling ⬇️

artículo científico publicado el 1 de marzo de 2013

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists ⬇️

artículo científico publicado el 20 de septiembre de 2010

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

artículo científico publicado en 2013

Tocilizumab versus adalimumab for rheumatoid arthritis – Authors’ reply ⬇️

artículo científico publicado el 3 de agosto de 2013

Total hip prosthetic joint infection due to Veillonella species

artículo científico publicado en 2004

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab

artículo científico publicado en 2017

Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection

artículo científico publicado en 2018

[Septic arthritis].

artículo científico publicado en 2006

β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion

artículo científico publicado en 2018

Lista de obras de

A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease

A systematic review of infliximab in the treatment of early rheumatoid arthritis

Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions

Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory

Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee

Adverse events of biologic therapies

Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis

Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.

Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice ⬇️

Assessment of the efficacy of different statins in murine collagen-induced arthritis

At the horizon of innovative therapy in rheumatology: new biologic agents

Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

CD14 is an acute-phase protein

Cardiovascular risk in patients with rheumatoid arthritis

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies

Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome ⬇️

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

Cytokine inhibitors in the treatment of rheumatoid arthritis

Cytokines in the rheumatic diseases

Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice

Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency ⬇️

Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Elevated serum levels of free interleukin-18 in adult-onset Still's disease

Endogenous IL-1α is a chromatin-associated protein in mouse macrophages ⬇️

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

Expression and function of junctional adhesion molecule-C in human and experimental arthritis

Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis

Hand osteoarthritis: new insights

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

IL-1 pathways in inflammation and human diseases

IL-1 trap. Regeneron/Novartis.

IL-1, IL-18, and IL-33 families of cytokines

IL-1R1-MyD88 axis elicits papain-induced lung inflammation.

IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells

IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro

Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study

Immune-mediated experimental arthritis in IL-33 deficient mice

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians

Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis.

Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

Interleukin-33 biology with potential insights into human diseases ⬇️

Interleukin-33 is biologically active independently of caspase-1 cleavage

Interleukin-6 and chronic inflammation

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus

Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system

Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility

Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease

Is IL-1 a good therapeutic target in the treatment of arthritis?

Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?

Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis ⬇️

Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa B/PU.1 binding site

Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition

Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection

Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice

Mice deficient in hepatocyte‐specific IL‐1Ra show delayed resolution of concanavalin A‐induced hepatitis ⬇️

Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein